Troxevasin (troxerutin) gel 2% 40g

1 g of gel for external use contains:
Active substance:
troxerutin 20 mg;
Excipients:
carbomer - 6 mg, trolamine (triethanolamine) - 7 mg,
disodium edetate dihydrate - 0.5 mg,
benzalkonium chloride - 1 mg,
purified water - 965.5 mg.
Troxevasin is an angioprotective agent that acts primarily on capillaries and veins.
Reduces pores between endothelial cells by modifying the fibrous matrix located between endothelial cells.
Inhibits aggregation and increases the degree of deformation of red blood cells; It has an anti-inflammatory effect.
In chronic venous insufficiency, Troxevasin reduces the severity of edema, pain, seizures, trophic disorders, varicose ulcers. Relieves the symptoms associated with hemorrhoids - pain, itching and bleeding.
Due to the beneficial effect of Troxevasin on the permeability and resistance of capillary walls, it helps to slow the development of diabetic retinopathy. In addition, its effect on the rheological properties of blood helps prevent retinal vascular microthrombosis.
Indications
Chronic venous insufficiency, postphlebitis syndrome, trophic disorders in varicose veins and trophic ulcers. As an adjunct treatment after sclerotherapy of veins and removal of varicose nodes. Hemorrhoids (pain, exudation, itching and bleeding).
Venous insufficiency and hemorrhoids during pregnancy, starting from the II trimester.
As an adjunct treatment of retinopathy in patients with diabetes mellitus, arterial hypertension and atherosclerosis.
Contraindications
Hypersensitivity to rutosides or to other components of the drug.
The gel is applied to the affected areas with light, massaging movements until it is completely absorbed 2 times / day in the morning and evening.
The use of Troxevasin is possible as one of the components of a comprehensive treatment.
The gel should only be applied to intact skin.
Do not apply to open wounds, eyes and mucous membranes.